| Date | Form | Description | Docs | XBRL | Pages |
| 07/31/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 07/21/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 06/14/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
19 |
| 05/01/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 04/17/23 | 8-K | Current report filing |
|
|
5 |
| 03/17/23 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
|
17 |
| 03/10/23 | 8-K | Current report filing |
|
|
24 |
| 01/27/23 | DEF 14A | Definitive proxy statements |
|
17 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 | |
| 01/04/23 | 4 | Statement of changes in beneficial ownership of securities |
|
1 |
Latest News & Events
Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy
Read More...Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology
Read More...Anixa Biosciences Announces $5 Million Share Repurchase Program
Read More...